Our clients operate in a heavily regulated industry with a constantly changing regulatory landscape. Compliance and regulatory considerations span an entire organization and lay the framework for:
- ensuring safety and compliance
- measuring quality and performance
- sharing healthcare information and data
- optimizing workforce
- hiring, credentialing and enrolling providers
- tracking facility access and security
Multiple agencies govern compliance within the healthcare realm including DOJ, OIG, FDA, CMS, TJC. Consequences for non-compliance with applicable regulations include substantial financial penalties such as fines, lawsuit settlements, and exclusion from government programs, such as Medicaid and Medicare.
Given the financial and reputational impact of compliance issues, A&M clients benefit from HIG’s compliance experts to assess the range of risk and regulatory exposure and to quantify the ROI of a comprehensive compliance implementation against impact of regulatory fines. Our HIG Compliance and Regulatory service is led by skilled, widely respected former compliance executives and high-ranking government officials with unique, firsthand experience and perspectives. With the capacity to fully assess a healthcare organization’s exposure areas, our team is equipped to provide implementation roadmaps for improvement and reorganize compliance and legal departments to maximize business functions.
RELY ON US FOR HELP WITH:
| Compliance and Quality Program Assessment and Operation Enforcement and Exposure Review and Solution Design |
|
Privacy and Security Program Review and Operations |
| |
|
|
- Assess Compliance Program Effectiveness
- Identify Compliance and/or Quality Program Gaps
- CCO Engagements
- Custom Compliance Education and Training
- Board of Director Education and Advice
- Reporting Relationships, Roles and Responsibilities
- Conflict of Interests
|
|
- Program Design and Implementation
- Privacy and Security Audits
- Risk Assessments
- Breach Evaluation and Response
|
| |
|
|
| Government Investigations and Settlements |
|
Fraud, Waste, and Abuse Investigations |
| |
|
|
- Monitor Corporate Integrity Agreements (CIAs) and Assist with Reporting Activities
- Develop and Implement Corrective Action Plans
- Repayment Analysis
- “Ability to Pay” Presentations
|
|
- Assist with Internal Investigations and Self-Disclosure Protocols
- Regulatory Agency Interfaces and Reporting
- Auditing and monitor for compliance with False Claims Act and Fraud, Waste, and Abuse Regulations
|
| |
|
|
| Licensing and Accreditation Services |
|
Interim Management |
| |
|
|
- Auditing and monitoring for compliance with Medicare Conditions of Participation and Accreditation Standards
- Accreditation Survey Preparation and Response (e.g., NCQA, URAC, JCAHO, AAAHC)
- Quality Assurance and Performance Improvement Plan
|
|
- Chief Compliance Officer
- Chief Privacy Officer
- Chief Security Officer
- Chief Risk Officer
|
| |
|
|
| Process, Redesign, and Implementation Services Management Advisory Services |
|
Risk Assessment and Management Operational Due Diligence |
| |
|
|
- Operational Performance Improvement Strategies
- Governing Boards and Senior Management Collaboration
|
|
- Risk Management and Process Improvements
- Liability/Loss Mitigation
|
| |
|
|
| Transaction Support |
|
|
| |
|
|
- Pre and Post Acquisition / Merger Due Diligence
- Integration Support
|
|
|
OPTIONS TO SUPPORT VIABILITY FOR AUSTRALIA’S PRIVATE HOSPITAL SYSTEM
July 3, 2025
The Australian healthcare system has long been recognised as a global leader, balancing public, and private care to deliver exceptional outcomes for patients.This paper outlines a pathway to safeguard the future of Australia’s private hospital network
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
